相关实验视频
Updated: Feb 9, 2026

05:49
Protein Engineering by Yeast Surface Display
Published on: November 29, 2024
3.6K
工程外细胞囊泡显示双特异性T细胞参与者,用于针对性治疗B细胞恶性瘤
Xiuxiu Yang1,2, Qian Xu3,4, Jue Wang3
1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, 300020, China.
Experimental hematology & oncology
|February 7, 2026
概括
一个新的双功能细胞外囊泡 (EV) 平台,BiTE EV@STA,结合了双特异性T细胞参与剂 (BiTEs) 与STING激动剂 (STA). 这种免疫疗法激活了适应性和先天性免疫力,克服了B细胞恶性瘤的抵抗力.
科学领域:
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
- 在瘤学瘤学.
背景情况:
- 基于T细胞的免疫疗法,如CAR-T和双特异性T细胞参与剂 (BiTEs),表现出成功,但在B细胞恶性瘤中面临抵抗和免疫抑制.
- 瘤微环境 (TME) 对有效的癌症免疫疗法构成重大障碍.
- 需要新的策略来克服治疗耐药性并增强对血液恶性瘤的免疫反应.
研究的目的:
- 开发和评估一个新的双功能细胞外囊泡 (EV) 平台,BiTE EV@STA,用于增强免疫疗法.
- 在电动汽车中研究表面显示的BiTE和封装的STING激动剂 (STA) 的联合作用.
- 评估BiTE EV@STA在克服TME介导耐药性和改善B细胞恶性瘤治疗结果方面的潜力.
主要方法:
- 设计出细胞外囊泡 (EVs),以在其表面显示抗CD3/CD19BiTE分子.
- 在工程电动汽车中封装了一个STING激动剂 (STA),创建了BiTE EV@STA平台.
- 在Nalm6-Luc异种移植模型中评估了药理动力学,瘤向,T细胞介导的细胞毒性,细胞因子释放和体内疗效.
主要成果:
- BiTE EVs表现出有利的药理动力学,增强瘤向性,以及强大的T细胞依赖性细胞毒性和细胞因子释放.
- 在异种移植模型中,BiTE EV@STA显示出显著的瘤进展抑制和延长存活时间.
- 与单个成分相比,BiTE EV@STA激活了树突细胞,增加了CD8+ T细胞的透,并实现了4倍的瘤生长抑制.
结论:
- BiTE EV@STA是一种有前途的基于EV的免疫疗法,可以同时激活适应性和先天性免疫力.
- 这种双激活策略有效地克服了B细胞恶性瘤中TME介导的抗性.
- BiTE EV@STA平台具有很大的潜力,可以在血液癌症及其他疾病中推进基于T细胞的疗法.
相关概念视频
Cell Specific Gene Expression
16.6K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.6K
Cell Specific Gene Expression
5.6K
5.6K
Targeted Cancer Therapies
8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.9K
Target Cell Response to Hormones
5.8K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.8K
Stem Cell Therapy for Tissue Regeneration
4.7K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.7K
What is Genetic Engineering?
80.3K
Overview
80.3K

